Cubans develop synthetic vaccines

Cuban researchers have produced the first synthetic vaccine against pneumonia and meningitis, press reports said on Saturday.

    Discovery may lead to the future of disease prevention

    Vicente Verez, head of the University of Havana's Antigen Research Center, told the Cuban press agency AIN the vaccine would be presented to a biotechnology congress in Havana from 23-28 November.

    He said the vaccine was designed to be administered to infants in three doses - at two, four and six months - with a booster at 18 months.

    Clinical studies done in Camaguay in central Cuba showed that more than 99% of babies vaccinated developed antibodies against the pneumonia and meningitis viruses as well as other diseases, he said.

    Synthetically produced vaccines offer many advantages over conventional vaccines, including enhanced purity and effectiveness. They also have a longer shelf life and can be mass produced, potentially at a lower cost.

    SOURCE: AFP


    YOU MIGHT ALSO LIKE

    From the US to Afghanistan: Rediscovering the mother who left me

    From the US to Afghanistan: Rediscovering the mother who left me

    Tracee Herbaugh's mother, Sharon, abandoned her when she was born, pursuing a career from which she never returned.

    Could mega-dams kill the mighty River Nile?

    Could mega-dams kill the mighty River Nile?

    For Ethiopia, a new dam holds the promise of much-needed electricity; for Egypt, the fear of a devastating water crisis.

    The evening death came for me: My journey with PTSD

    The evening death came for me: My journey with PTSD

    On a gorgeous Florida evening, a truck crashed into me. As I lay in intensive care, I learned who had been driving it.